A Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants

Recruiting Observational Study
Cryptosporidiosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 Months – 59 Months
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Novartis Pharmaceuticals · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to characterize the pediatric cryptosporidiosis disease profile with respect to clinical presentation.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Age 6 months to 59 months with diarrhea according to the World Health Organization (WHO) criteria (≥3 loose stools daily for at least 2 days) * QuikChek™ and Stool microscopy positive for Cryptosporidium at screening * Acute (\<7 days), prolonged (lasting 7-13 days), persisten…
Contacts

Novartis Pharmaceuticals

+41613241111

novartis.email@novartis.com

CONTACT

Novartis Pharmaceuticals

CONTACT